More stories

  • in

    US disburses $3.4 billion in budget aid for Ukraine, Yellen says

    WASHINGTON (Reuters) – The United States has sent $3.4 billion in additional budget aid to Ukraine, giving the war-torn country critical resources amid intensifying Russian attacks on Ukrainian civilians and infrastructure, Treasury Secretary Janet Yellen said on Monday.Yellen said in a statement the direct budget assistance, provided in coordination with the U.S. Agency for International Development and the State Department, marked the final disbursement under the 2024 Ukraine Security Supplemental Appropriations Act.A U.S. official said the funding brings the total in U.S. budget aid to Ukraine to just over $30 billion since Russia’s invasion in February 2022. Most of those funds are used to keep Ukraine’s government running by paying salaries to teachers and other state employees. Earlier on Monday, U.S. President Joe Biden announced $2.5 billion in additional security assistance for Ukraine, which is separate from the direct budget aid. Nearly three years into the war, Washington has committed $175 billion in total assistance for Ukraine.President Joe Biden’s administration has been racing to shore up support for Ukraine before Republican President-elect Donald Trump takes office on Jan. 20, given his public questioning of military aid and vows to end the Ukraine war within 24 hours of taking office.Trump wants Ukraine’s President Volodymyr Zelenskiy to make a deal with Russian President Vladimir Putin to end the nearly three-year-old Ukraine war. Some of his fellow Republicans, who will control both houses of the U.S. Congress starting next month, have also cooled on sending more aid to Kyiv.Yellen said continued economic aid for Ukraine was crucial to allow it to maintain government services and continue to defend its sovereignty, warning against moves to cut funding.”Ukraine’s success is in America’s core national interest,” she said, vowing to continue to pressure Moscow with sanctions and to help position Ukraine to achieve a just peace. “We must not retreat in this effort,” she said.She stressed that U.S. budget aid for Ukraine has been and remains conditioned on reforms aimed at strengthening law enforcement, improving the transparency and efficiency of government institutions, and bolstering anti-corruption efforts.The latest funding came on top of the $20 billion U.S. portion of a $50 billion Group of Seven loan for Ukraine that Treasury transferred to a World Bank intermediary fund for Ukraine earlier this month. Those funds are backed by profits earned on frozen Russian sovereign assets.Biden on Wednesday said he had asked the Defense Department to continue its surge of weapons deliveries to Ukraine, after condemning Russia’s Christmas Day attack on Ukraine’s energy system and some of its cities.   More

  • in

    Weathering the blustery trade winds of 2024

    $75 per monthComplete digital access to quality FT journalism with expert analysis from industry leaders. Pay a year upfront and save 20%.What’s included Global news & analysisExpert opinionFT App on Android & iOSFT Edit appFirstFT: the day’s biggest stories20+ curated newslettersFollow topics & set alerts with myFTFT Videos & Podcasts20 monthly gift articles to shareLex: FT’s flagship investment column15+ Premium newsletters by leading expertsFT Digital Edition: our digitised print edition More

  • in

    Wall St futures slip on elevated Treasury yields

    At 05:36 a.m. ET, Dow E-minis were down 78 points, or 0.18%, S&P 500 E-minis were down 12.75 points, or 0.21%, and Nasdaq 100 E-minis were down 43.75 points, or 0.20%.Equities tend to do well in the last five trading days of December and into the first two days of January, a phenomenon dubbed the Santa Claus rally. The S&P 500 has gained 1.3% on average during the period since 1969, according to the Stock Trader’s Almanac.The benchmark index eked out marginal gains last week, with analysts pointing to a strong run earlier in the year that sent valuations soaring. The index has been trading in a bull market for over two years and is poised to end its second consecutive year with gains of more than 20%. Much of this year’s rally was fueled by optimism around interest rate cuts, artificial intelligence integration boosting corporate profitability and on expectations that President-elect Donald Trump’s policies could spur economic growth. However, some analysts expect Trump’s policies to be inflationary, with yields on U.S. Treasury notes across the curve pinned at multi-month highs. [US/]Since early December, the yield on the benchmark 10-year note has risen to touch its highest level since May 2024. On the day, it was slightly lower.Investors tempered their expectations on the total number of interest rate cuts by the Fed in 2025 after the institution struck a cautious tone at its meeting earlier in the month.They now expect the central bank to deliver its first rate reduction in May next year, according to the CME Group’s (NASDAQ:CME) FedWatch Tool. Later in the week, investors will scrutinize the Institute of Supply Management’s manufacturing activity survey for December and a weekly report on jobless claims, ahead of a key employment report due in the following week.Growth stocks weakened in premarket trading. Tesla (O:TSLA) dropped 1.6%, Meta (NASDAQ:META) dipped 0.5%, while chip company Broadcom (NASDAQ:AVGO) lost 0.6% and Nvidia (NASDAQ:NVDA) slipped 0.8%.South Korea ordered an emergency safety inspection of its entire airline operation system after the country’s worst air disaster over the weekend involving a Boeing (NYSE:BA) plane. Boeing’s shares were down 4.5%. Trading is expected to be impacted by thin volumes in the run up to the New Year holiday on Wednesday and is likely to remain subdued until Jan. 6. More

  • in

    FirstFT: Jimmy Carter dies at the age of 100

    $75 per monthComplete digital access to quality FT journalism with expert analysis from industry leaders. Pay a year upfront and save 20%.What’s included Global news & analysisExpert opinionFT App on Android & iOSFT Edit appFirstFT: the day’s biggest stories20+ curated newslettersFollow topics & set alerts with myFTFT Videos & Podcasts20 monthly gift articles to shareLex: FT’s flagship investment column15+ Premium newsletters by leading expertsFT Digital Edition: our digitised print edition More

  • in

    Pakistan’s economy grows 0.92% in Q1 of ongoing fiscal year

    The South Asian country is navigating a challenging economic recovery path and has been buttressed by a $7 billion facility from the International Monetary Fund (IMF) in September.The growth was driven by positive performances in the agriculture and services sectors, which grew by 1.15% and 1.43%, respectively, in the first quarter of the fiscal year which ends in June 2025.Pakistan’s economy grew by 2.69% year-on-year in the first quarter of the previous 2023-24 fiscal year.However, the industrial sector contracted by 1.03%, mainly due to a decline in mining and quarrying activities during July-September, read the report. The committee compiling the national accounts approved the introduction of quarterly estimates of expenditure of the economy.On the basis of latest figures of the national accounts aggregates for the last fiscal year, the overall size of the economy stood at 105.6 trillion Pakistani rupees ($379.31 billion).Annual per capita income in rupees was recorded at 472,263 Pakistani rupees ($1,696.35).The committee also approved an updated annual growth rate for the last fiscal year 2023-24, which stood at 2.50%, slightly lower than the previously estimated 2.52%. ($1 = 278.4000 Pakistani rupees) More

  • in

    FDA approves injectable version of Bristol Myers Squibb’s cancer drug Opdivo

    (Reuters) -The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers (NYSE:BMY) Squibb’s blockbuster cancer drug, Opdivo.Opdivo is part of a class of drugs called PD-1 inhibitors, which enhance the immune system’s ability to fight cancer by removing its natural brakes.Like other PD-1 drugs such as Merck (NS:PROR)’s Keytruda, it was previously available through infusions and patients received it via an intravenous drip in a health office. The new injectable form is expected to be more convenient for patients and could help shield the company from erosion of sales when the patent for the intravenous version expires later this decade.The injection, branded as Opdivo Qvantig, has been approved to treat all previously approved adult, solid tumor indications, either on its own, as maintenance therapy or in combination with chemotherapy.The drug will be available in early January, and will be priced at parity with the list price of the IV version, Adam Lenkowsky, Bristol’s chief commercialization officer, told Reuters ahead of the approval.The IV version of the drug has a list price of $7,635 per infusion for two weeks for the lower dose and $15,269 per infusion for four weeks for the higher 480-milligram dose.The approval was based on data from a late-stage study, which showed that the subcutaneous form of the drug was not inferior to the intravenous formulation in patients with advanced kidney cancer who have received prior systemic therapy.The drugmaker is relying on newer treatments like Opdivo Qvantig to drive growth as patents on older drugs, such as cancer drug Revlimid and blood thinner Eliquis, expire later this decade.Opdivo Qvantig was co-formulated with Halozyme Therapeutics (NASDAQ:HALO)’ drug delivery technology, which helps reduce treatment administration from hours-long IV infusions to subcutaneous injections delivered in minutes. More

  • in

    Analysis-Lula’s embrace of new Brazil central banker has markets wary

    BRASILIA (Reuters) – After months of rancor, ties between President Luiz Inacio Lula da Silva and Brazil’s central bank look poised for an era of sweetness and light – which is precisely what worries some investors.Gabriel Galipolo, 42, is set to take the reins at the bank on Wednesday. The former deputy finance minister has earned a reputation for economic views that sometimes stray from his predecessor’s embrace of free markets but warm the hearts of left-leaning politicians. While that should help quiet months of sniping from a president exasperated with high interest rates, it may test the new formal independence of that institution, six of its former directors told Reuters.Galipolo takes over from central bank governor Roberto Campos Neto, an appointee of former President Jair Bolsonaro, in the first transition since a 2021 law that required heads of state to wait two years before naming their own central bank chief, in a move designed to boost the bank’s autonomy.The handoff will be scrutinized after frustration with government spending plans triggered a market meltdown, sending Brazil’s risk premium surging and its currency to all-time lows.The central bank declined a request for comment from Galipolo, who now serves as one of its policy directors.Galipolo and Campos Neto have played down their differences and vowed continuity at a shared news conference on Dec. 19.Now leading the country in his third nonconsecutive term, Lula praised Galipolo in a social media video on Dec. 20, vowing fiscal discipline and a hands-off stance toward the central bank. Concerns remain, however, about a shift in monetary policy, dating back to a split policy decision in May when Galipolo and three other Lula appointees voted for a larger rate cut than the Bolsonaro-appointed majority. Starting in January, Lula’s picks will hold seven of the nine seats on the central bank’s rate-setting committee, or Copom.All five of the central bank’s rate decisions since May have been unanimous, including December’s bigger-than-expected 100 basis-point hike that came with surprising policy guidance of planned increases of the same size in January and March of 2025. Despite the united front and hawkish rhetoric from Galipolo, who has pledged independence from Lula, some economists say the market remains unconvinced. “The forward guidance was issued precisely because there are concerns,” said former central bank director Alexandre Schwartsman, appointed during Lula’s first term in 2003. “It’s a symptom, a recognition there are serious doubts about how (Galipolo) will behave, whether he will truly be independent or not.” “We’ll see the true outcome after March,” he added. “Until then, the ghosts of Copom past will hold sway.”LONG SHADOWOne such phantom is that of Alexandre Tombini, the last central bank governor appointed by Lula’s leftist Workers Party. On his watch in late 2012, Copom cut rates and kept them at a record low despite inflation shooting away from the official target.Many economists criticized Tombini for ceding to pressure from then-President Dilma Rousseff to keep borrowing costs low, adding to imbalances in Brazil’s economy that eventually tipped the country into its worst recession in decades.Lula’s allies instead cite his relationship with Henrique Meirelles, whom he tapped to run the central bank during his first two terms from 2003 to 2010 when aggressive monetary policies eventually paved the way for a robust economic boom.Meirelles told Reuters he was confident Lula would respect the central bank’s independence as he had in his prior terms.”If it’s good for the country, it’s good for the government. As long as Lula trusts in this, the relations are likely to become less tense,” Meirelles said in a telephone interview, adding that investors’ biggest concern is Brazil’s surging public debt.Brazil’s Treasury forecasts the country’s gross debt will have climbed by 10 percentage points over Lula’s term to 81.7% of GDP by 2026, considered exceptionally high among emerging-market peers.With less than two years before the next election, aides say Lula has been especially impatient about obstacles to economic growth, including high interest rates.Relations with Campos Neto were also soured from the start after the central bank chief voted in the 2022 election wearing a soccer jersey favored by Bolsonaro’s supporters. Adding insult to injury, he attended a dinner in his honor in June held by Sao Paulo Governor Tarcisio de Freitas, seen as one of Lula’s strongest challengers in 2026.Campos Neto has said central bank officials can be close to political actors while maintaining their independence.Setting aside Lula’s baggage with Campos Neto, some say his personal relationship with Galipolo, whom he has called a “gift” and “a golden boy,” may have swung too far in the other direction.Galipolo joined Lula for bilateral meetings with foreign heads of state in Rio de Janeiro during a summit of the Group of 20 major economies in November and tagged along with Finance Minister Fernando Haddad for meetings in Washington the month before, the kind of events from which Campos Neto was notably absent.Still, opposition lawmakers have praised Galipolo’s qualifications and a Senate committee unanimously approved his nomination. With economic growth around 3.5% in 2024 and record-low unemployment, tight monetary policy has faced limited public backlash. However, former central bank officials believe the real challenge for Galipolo will come when the central bank needs to maintain its position as the economy cools and unemployment rises – a more sensitive issue for a left-leaning government. More

  • in

    European stocks slip as bond yields stay high

    (Reuters) -European stocks edged lower on Monday as elevated government bond yields prompted investors to pull out of equities at the end of a year that has been positive for some regional markets.The pan-European STOXX 600 index dropped 0.3% by 0947 GMT, with technology and industrial goods makers leading broad-based declines.Trading volumes were thin ahead of the New Year holiday on Wednesday. Stock markets in Germany, Italy and Switzerland are shut on Tuesday as well, while those in the UK and France have a half-day trading session.The 10-year German bund yield traded at its highest since mid-November, tracking a rise in U.S. Treasury yields, as uncertainty around monetary policy next year and prospects of inflationary policies under a Trump presidency weighed on investor sentiment.The STOXX 600 is still on course for a 5.9% annual rise, with German stocks leading regional gains and French shares lagging.Still, the European benchmark lags the S&P 500’s 25% surge this year as interest rate cuts from the Federal Reserve and a boom in AI trades boosted Wall Street’s tech behemoths. “The surging S&P 500 and Nasdaq underscore the market’s tech-fuelled triumph, though last Friday’s sell-off, triggered by climbing Treasury yields, was a sobering reminder of lingering rate concerns,” said Matt Britzman, senior equity researcher at Hargreaves (LON:HRGV) Lansdown.The German DAX dipped 0.3% on its final trading day of the year but looked on course for a 19% annual surge, making it the top performer this year among major European bourses.On the flip side, France’s CAC 40 was set for an annual drop of 2.5%, driven by concerns about the country’s spiralling fiscal deficit and political turmoil. Siemens (ETR:SIEGn) Healthineers dipped 1.2% after Siemens AG (OTC:SIEGY)’s Chief Financial Officer Ralf Thomas told the Handelsblatt newspaper that the German technology group is reviewing its majority stake in its medical technology unit.BayWa surged 12% after the Munich-based trader of farming supplies and produce said it had reached a restructuring agreement with its major shareholders and financiers. More